You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,586,010

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,586,010 protect, and when does it expire?

Patent 9,586,010 protects EPIPEN and EPIPEN JR. and is included in one NDA.

This patent has forty-seven patent family members in eighteen countries.

Summary for Patent: 9,586,010

Patent landscape, scope, and claims:

Title:	Automatic injector with needle cover
Abstract:	An auto-injector automatically dispenses a predetermined dose of medicament upon activation. The auto-injector includes a needle cover operative to engage an injection site and activate the injector. The needle cover is configured to move from a locked retracted position prior to a medicament dispensing operation to a locked extended position after the medicament dispensing operation. The non-removable needle cover prevents contact with the needle both before and after the medicament dispensing operation.
Inventor(s):	Mesa; C. Michael (Boyds, MD), Tomellini; Dalita Rosemarie (Rehoboth, MA), Bremley; Mark Bumb (Edwardsville, IL), Raven; Sophie Rebecca (Swavesey, GB), Murphy; Martin Joseph (Letchworth Garden City, IE), Rochford; Craig Malcolm (Andover, GB), Kirkwood; Stephen Philip (Haynes, GB)
Assignee:	Meridian Medical Technologies, Inc. (Columbia, MD)
Application Number:	13/788,509
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,586,010
Patent Claim Types: see list of patent claims	Use; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,586,010

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mylan Speciality Lp	EPIPEN	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	019430-001	Dec 22, 1987	AB	RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y				⤷ Subscribe
Mylan Speciality Lp	EPIPEN JR.	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	019430-002	Dec 22, 1987	AB	RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,586,010

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2005271355	⤷ Subscribe
Australia	2010201665	⤷ Subscribe
Australia	2013222015	⤷ Subscribe
Canada	2576776	⤷ Subscribe
Canada	2683253	⤷ Subscribe
China	101166551	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.